Clinical Trials
7 trialsNCT06745583 2026-06-03
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Phase 2 Recruiting
NCT07614243 2026-05-29
ZFAS1-BIPN
The First Affiliated Hospital of Zhejiang Chinese Medical University
Phase NA Completed
NCT04266665 2026-03-25
Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome
Aristotle University Of Thessaloniki
Phase 4 Completed
NCT04806620 2026-01-22
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
Recruiting
NCT06322342 2025-12-26
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Phase 2 Completed
NCT06112639 2025-01-10
DANCEREX-DTx
Fondazione Don Carlo Gnocchi Onlus
Phase NA Recruiting
NCT03014518 2021-07-16
Biomarkers as Predictors of Suicidal Risk in Adolescents
The Cleveland Clinic
Completed